{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:20:07Z","timestamp":1792624807458,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ogla.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T05:47:30Z","timestamp":1632462450000},"page":"284-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cost-Effectiveness Analysis of Minimally Invasive Trabecular Meshwork Stents with Phacoemulsification"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2785-6100","authenticated-orcid":false,"given":"Shefali","family":"Sood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-6163","authenticated-orcid":false,"given":"Noah","family":"Heilenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9432-1662","authenticated-orcid":false,"given":"Sherry","family":"Glied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama A.","family":"Al-Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2021.09.006_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcjo.2016.07.013","article-title":"Glaucoma treatment trends: a review","volume":"52","author":"Conlon","year":"2017","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ophtha.2007.11.023","article-title":"Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study","volume":"115","author":"Friedman","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ICL.0000000000000544","article-title":"Ocular surface disease and glaucoma medications: a clinical approach","volume":"45","author":"Zhang","year":"2019","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ogla.2021.09.006_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajo.2011.10.024","article-title":"Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up","volume":"153","author":"Gedde","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib5","article-title":"Epidemiology of glaucoma: the past, present, and predictions for the future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ogla.2021.09.006_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/IIO.0000000000000192","article-title":"Surgical innovations in glaucoma: the transition from trabeculectomy to MIGS","volume":"57","author":"Chou","year":"2017","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ogla.2021.09.006_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ophtha.2018.05.012","article-title":"A\u00a0Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON Study","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","article-title":"Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ogla.2021.03.012","article-title":"Trends and usage patterns of minimally invasive glaucoma surgery in the United States: IRIS\u00ae Registry Analysis 2013\u20132018","volume":"4","author":"Yang","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2021.09.006_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40123-018-0131-0","article-title":"Systematic literature review of clinical and economic outcomes of micro-invasive glaucoma surgery (MIGS) in primary open-angle glaucoma","volume":"7","author":"Agrawal","year":"2018","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ogla.2021.09.006_bib11","first-page":"760","article-title":"Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma","volume":"20","author":"Berdahl","year":"2017","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.ogla.2021.09.006_bib12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ophtha.2009.02.022","article-title":"Glaucoma care cost-effectiveness","volume":"116","author":"Hoskins","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/13696998.2019.1572013","article-title":"Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada","volume":"22","author":"Patel","year":"2019","journal-title":"J Med Economics"},{"key":"10.1016\/j.ogla.2021.09.006_bib14","article-title":"The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea","volume":"98","author":"Choi","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ogla.2021.09.006_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archophthalmol.2011.2727","article-title":"Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma","volume":"130","author":"Stein","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874364100903020059","article-title":"Staging glaucoma patient: why and how?","volume":"3","author":"Susanna","year":"2009","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.ogla.2021.09.006_bib17","first-page":"66","article-title":"United States, Life Tables\u00a02017","volume":"68","author":"Arias","year":"2019","journal-title":"Natl Vit Stat Rep"},{"key":"10.1016\/j.ogla.2021.09.006_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajo.2020.05.019","article-title":"Rates of glaucomatous structural and functional change from a large clinical population: the Duke Glaucoma Registry Study","volume":"222","author":"Jammal","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ophtha.2020.06.027","article-title":"Impact of intraocular pressure control on rates of retinal nerve fiber layer loss in a large clinical population","volume":"128","author":"Jammal","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ophtha.2020.11.004","article-title":"Three-year findings of the HORIZON Trial: a Schlemm canal microstent for pressure reduction in primary open-angle glaucoma and cataract","volume":"128","author":"Ahmed","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/IJG.0000000000001716","article-title":"Three-year outcomes of second-generation trabecular micro-bypass stents (iStent inject) with phacoemulsification in various glaucoma subtypes and severities","volume":"30","author":"Salimi","year":"2021","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2021.09.006_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ogla.2019.11.009","article-title":"A\u00a0Canadian cost-utility analysis of 2 trabecular microbypass stents at time of cataract surgery in patients with mild to moderate open-angle glaucoma","volume":"3","author":"Ahmed","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2021.09.006_bib23","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2012.02.050","article-title":"Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study","volume":"119","author":"Mansberger","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib24","article-title":"Cost-effectiveness analysis of iStent and phacoemulsification versus glaucoma medications in the Ontario Health Insurance Plan (OHIP)","volume":"55","author":"Iordanous","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2021.09.006_bib25","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","article-title":"Patterns of glaucoma medication adherence over four years of follow-up","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ophtha.2019.09.041","article-title":"Cost-utility analysis of glaucoma medication adherence","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib27","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ophtha.2017.05.024","article-title":"Brand medications and Medicare Part D: How eye care providers' prescribing patterns influence costs","volume":"125","author":"Newman-Casey","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/jop.2018.0114","article-title":"Patient preference-based comparative effectiveness and cost-utility analysis of the prostamides for open-angle glaucoma","volume":"35","author":"Brown","year":"2019","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ogla.2021.09.006_bib30","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ophtha.2007.06.008","article-title":"The impact of anchor point on utilities for 5 common ophthalmic diseases","volume":"115","author":"Lee","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness \u2014 the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogla.2021.09.006_bib32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ogla.2021.09.006_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2013.09.003","article-title":"Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota","volume":"121","author":"Malihi","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2013.05.027","article-title":"Lifetime risk of blindness in open-angle glaucoma","volume":"156","author":"Peters","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib35","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.4.2.1","article-title":"Why do people (still) go blind from glaucoma?","volume":"4","author":"Susanna","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ogla.2021.09.006_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bjo.85.3.327","article-title":"Utility values associated with blindness in an adult population","volume":"85","author":"Brown","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amepre.2013.02.018","article-title":"Age-related eye diseases and visual impairment among U.S. adults","volume":"45","author":"Chou","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ogla.2021.09.006_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ophtha.2019.04.034","article-title":"A\u00a0prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: The COMPARE Study","volume":"127","author":"Ahmed","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2021.09.006_bib39","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10792-020-01314-7","article-title":"Comparative efficacy and cost\u2013utility of combined cataract and minimally invasive glaucoma surgery in primary open-angle glaucoma","volume":"40","author":"Bartelt-Hofer","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib40","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.jval.2019.04.1015","article-title":"PMD18 a cost-utility analysis of two trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in France","volume":"22","author":"Nieland","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.ogla.2021.09.006_bib41","doi-asserted-by":"crossref","first-page":"S671","DOI":"10.1016\/j.jval.2019.09.1426","article-title":"PMD13 cost-utility analysis of istent inject in mild to moderate primary open-angle glaucoma in Japan","volume":"22","author":"Igarashi","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.ogla.2021.09.006_bib42","series-title":"Minimally Invasive Glaucoma Surgery (MIGS) for Individuals With Glaucoma. A Health Technology Assessment","author":"Lund","year":"2021"},{"key":"10.1016\/j.ogla.2021.09.006_bib43","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/IJG.0000000000001728","article-title":"Changes in prices and eye-care providers prescribing patterns of glaucoma medications in the United States between 2013 and 2019","volume":"30","author":"Barayev","year":"2021","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2021.09.006_bib44","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jamaophthalmol.2018.3672","article-title":"A\u00a0worldwide price comparison of glaucoma medications, laser trabeculoplasty, and trabeculectomy surgery","volume":"136","author":"Zhao","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0039-6257(77)90094-7","article-title":"Some aspects of the automation of perimetry","volume":"22","author":"Fankhauser","year":"1977","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/eye.2010.202","article-title":"Assessment of rates of structural change in glaucoma using imaging technologies","volume":"25","author":"Mansouri","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.ogla.2021.09.006_bib47","first-page":"1056573","article-title":"Glaukos iStent inject\u00ae trabecular micro-bypass implantation associated with cataract surgery in patients with coexisting cataract and open-angle glaucoma or ocular hypertension: a long-term study","volume":"2016","author":"Arriola-Villalobos","year":"2016","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ogla.2019.03.004","article-title":"Five-year, prospective, randomized, multi-surgeon trial of two trabecular bypass stents versus prostaglandin for newly diagnosed open-angle glaucoma","volume":"2","author":"Fechtner","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2021.09.006_bib49","article-title":"Real-world efficacy of the Hydrus microstent in Black and Afro-Latinx patients with glaucoma: a retrospective study","volume":"12","author":"Laroche","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40662-019-0157-y","article-title":"Hydrus microstent implantation for surgical management of glaucoma: a review of design, efficacy and safety","volume":"6","author":"Samet","year":"2019","journal-title":"Eye Vision"},{"key":"10.1016\/j.ogla.2021.09.006_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252130","article-title":"A\u00a0cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France","volume":"16","author":"Nieland","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ogla.2021.09.006_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0974-9233.148343","article-title":"Cataract surgery in the glaucoma patient","volume":"22","author":"Kung","year":"2015","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib53","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0886-3350(01)01036-7","article-title":"Effect of cataract surgery on intraocular pressure control in glaucoma patients","volume":"27","author":"Hayashi","year":"2001","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ogla.2021.09.006_bib54","first-page":"88","article-title":"Managing cataract surgery in patients with glaucoma","volume":"31","author":"Kyari","year":"2019","journal-title":"Community Eye Health"},{"key":"10.1016\/j.ogla.2021.09.006_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICU.0000000000000010","article-title":"The impact of cataract surgery on glaucoma care","volume":"25","author":"Shrivastava","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib56","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ogla.2021.09.006_bib57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","article-title":"Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up","volume":"153","author":"Gedde","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17469899.2016.1180246","article-title":"What rates of glaucoma progression are clinically significant?","volume":"11","author":"Saunders","year":"2016","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.ogla.2021.09.006_bib59","article-title":"Intraocular pressure lowering effect of the Hydrus Microstent implantation combined with cataract surgery in moderate to advanced glaucoma","volume":"59","author":"Toth","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419621002106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419621002106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:52:56Z","timestamp":1762887176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419621002106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2589419621002106"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2021.09.006","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness Analysis of Minimally Invasive Trabecular Meshwork Stents with Phacoemulsification","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}